SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Mountain CF. A new international staging system for lung cancer. Chest. 1986; 89: 225S233S.
  • 2
    Mountain CF. Revisions in the international system for staging lung cancer. Chest. 1997; 111: 17101717.
  • 3
    Naruke T,Goya T,Tsuchiya R, et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg. 1988; 96: 440447.
  • 4
    Cooper JD,Pearson G,Todd TR, et al. Radiotherapy alone for patients with operable carcinoma of the lung. Chest. 1985; 87: 289292.
  • 5
    Zhang HX,Yin WB,Zhang LJ, et al. Curative radiotherapy of early operable non-small cell lung cancer. Radiother Oncol. 1989; 14: 8994.
  • 6
    Talton BM,Constable WC,Kersh CR. Curative radiotherapy for technically operable stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys. 1990; 19: 1521.
  • 7
    Dosoretz DE,Katin MJ,Blitzer PH, et al. Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies. Int J Radiat Oncol Biol Phys. 1992; 25: 39.
  • 8
    Kupelian PA,Komaki R,Allen P. Prognostic factors in the treatment of node-negative nonsmall cell lung carcinoma with radiotherapy alone. Int J Radiat Oncol Biol Phys. 1996; 36: 607613.
  • 9
    Cheung PCF,Mackillop WJ,Dixon P, et al. Involved-field radiotherapy alone for early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2000; 48: 703710.
  • 10
    Haffty BG,Goldberg NB,Gerstley J, et al. Results of radical radiation therapy in clinical Stage I, technically operable non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 1988; 15: 6973.
  • 11
    Noordijk EM,vd Poest Clement E,Hermans J,Wever AM,Leer JW. Radiotherapy as an alternative to surgery in elderly patients with respectable lung cancer. Radiother Oncol. 1988; 13: 8389.
  • 12
    Sandler HM,Curran WJJr,Turrisi ATIII. The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 1990; 19: 913.
  • 13
    Ono R,Egawa S,Suemasu K, et al. Radiotherapy in inoperable stage I lung cancer. Jpn J Clin Oncol. 1991; 21: 125128.
  • 14
    Morita K,Fuwa N,Suzuki Y, et al. Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: retrospective analysis of 149 patients. Radiother Oncol. 1997; 42: 3136.
  • 15
    Kaskowitz L,Graham MV,Emami B, et al. Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 1993; 27: 517523.
  • 16
    Krol ADG,Aussems P,Noordijk EM, et al. Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation? Int J Radiat Oncol Biol Phys. 1996; 34: 297302.
  • 17
    Sibley GS,Jamieson TA,Marks LB, et al. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. Int J Radiat Oncol Biol Phys. 1998; 40: 149154.
  • 18
    Slotman BJ,Karim ABMF. Curative radiotherapy for technically operable stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys. 1994; 29: 3337.
  • 19
    Slotman BJ,Antonisse IE,Njo KH. Limited field irradiation in early stage (T1-2, N0) non-small cell lung cancer. Radiother Oncol. 1996; 41: 4144.
  • 20
    Hayakawa K,Mitsuhashi N,Nakajima N, et al. Radiation therapy for stage III epidermoid carcinoma of the lung. Lung Cancer. 1992; 8: 213224.
  • 21
    Graham PH,Gebski VJ,Langlands AO. Radical radiotherapy for early nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys. 1995; 31: 261266.
  • 22
    Gauden S,Ramsay J,Tripcony L. The curative treatment by radiotherapy alone of stage I non-small cell carcinoma of the lung. Chest. 1995; 108: 12781282.
  • 23
    Hayakawa K,Mitsuhashi N,Saito Y, et al. Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer. Lung Cancer. 1999; 26: 137142.
  • 24
    Rosenthal SA,Curran WJJr,Herbert SH, et al. Clinical stage II non-small cell lung cancer treated with radiation therapy alone. The significance of clinically staged ipsilateral hilar adenopathy (N1 disease). Cancer. 1992; 70: 34103417.
  • 25
    Jeremic B,Classen J,Bamberg M. Radiation therapy alone in technically operable, medically inoperable early stage (I/II) non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2002; 54: 119130.
  • 26
    Atagi S,Kawahara M,Ogawara M, et al. Phase II trial of daily low-dose carboplatin and thoracic radiotherapy in elderly patients with locally advanced non-small cell lung cancer. Jpn J Clin Oncol. 2000; 30: 5964.
  • 27
    Vansteenkiste JF,Stroobants SG,De Leyn PR, et al. Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: prospective analysis of 50 cases.Leuven Lung Cancer Group. Chest. 1997; 112: 14801486.
  • 28
    Steinert HC,Hauser M,Allemann F, et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology. 1997; 202: 441446.
  • 29
    Erasmus JJ,Patz EFJr,McAdams HP, et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol. 1997; 168: 13571360.
  • 30
    Kim BT,Lee KS,Shim SS, et al. Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT—a prospective study. Radiology. 2006; 241: 501509.
  • 31
    Hara R,Itami J,Kondo T, et al. Stereotactic single high dose irradiation of lung tumors under respiratory gating. Radiother Oncol. 2002; 63: 159163.
  • 32
    Whyte RI,Crownover R,Murphy MJ, et al. Stereotactic radiosurgery for lung tumors: preliminary results of a phase I trial. Ann Thorac Surg. 2003; 5: 10971101.
  • 33
    Hof H,Herfarth K,Munter M, et al. Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 2003; 56: 334341.
  • 34
    Zimmermann F,Geinitz H,Schill S, et al. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer. 2003; 48: 107114.
  • 35
    Fukumoto S,Shirato H,Shimizu S, et al. Small-volume image-guided radiotherapy using hypofractionated coplanar and noncoplanar multiple fields with inoperable stage I nonsmall cell lung carcinomas. Cancer. 2002; 95: 15461553.
  • 36
    Uematsu M,Shioda A,Suda A, et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small-cell lung cancer: a 5year experience. Int J Radiat Oncol Biol Phys. 2001; 51: 666670.
  • 37
    Nagata Y,Negoro Y,Aoki T, et al. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for 1 or 2 lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2002; 52: 10411046.
  • 38
    Lee S,Choi EK,Park HJ, et al. Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung Cancer. 2003; 40: 309315.
  • 39
    Onimaru R,Shirato H,Shimizu S, et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys. 2003; 56: 126135.
  • 40
    Timmerman R,Papiez L,McGarry R, et al. Extracranial stereotactic radioablation. Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest. 2003; 124: 19461955.
  • 41
    Wulf J,Hadinger U,Oppitz U,Thiele W,Ness-Dourdoumas R,Flentje M. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol. 2001; 177: 645655.
  • 42
    Jeremic B,Shibamoto Y,Acimovic LJ, et al. Hyperfractionated radiotherapy alone for clinical stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys. 1997; 38: 521525.
  • 43
    Jeremic B,Shibamoto Y,Acimovic LJ, et al. Hyperfractionated radiotherapy for clinical stage II nonsmall cell lung cancer. Radiother Oncol. 1999; 51: 141145.
  • 44
    Jeremic B,Milicic B,Acimovic L, et al. Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin/paclitaxel in patients with early stage (I/II) non-small cell lung cancer (NSCLC). Long-term results of a phase II study. J Clin Oncol. 2005; 23: 68736880.
  • 45
    Cox JD,Stetz J,Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for the Treatment and Research of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995; 31: 13411346.
  • 46
    Zimmermann FB,Bamberg M,Molls M, et al. Radiation therapy alone in early stage non-small-cell lung cancer. Semin Surg Oncol. 2003; 21: 9197.
  • 47
    Jeremic B,Shibamoto Y,Milicic B, et al. Impact of treatment interruptions due to toxicity on outcome of patients with early stage (I/II) non-small-cell lung cancer (NSCLC) treated with hyperfractionated radiation therapy (Hfx RT) alone. Lung Cancer. 2003; 40: 317323.
  • 48
    Jeremic B,Shibamoto Y,Acimovic L, et al. Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer. J Clin Oncol. 1995; 13: 452458.
  • 49
    Jeremic B,Shibamoto Y,Acimovic L, et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study. J Clin Oncol. 1996; 14: 10651070.
  • 50
    Jeremic B,Shibamoto Y,Milicic B, et al. Concurrent radiochemotherapy for patients with stage III non-small cell lung cancer (NSCLC). Long-term results of a phase II study. Int J Radiat Oncol Biol Phys. 1998; 42: 10911096.
  • 51
    Jeremic B,Shibamoto Y,Acimovic LJ, et al. Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without week-end carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: a randomized trial. Int J Radiat Oncol Biol Phys. 1998; 50: 1925.
  • 52
    Jeremic B,Shibamoto Y,Milicic B, et al. Short-term chemotherapy and palliative radiotherapy for elderly patients with stage IV non-small cell lung cancer. A phase II study. Lung Cancer. 1999; 24: 19.
  • 53
    Jeremic B,Shibamoto Y,Acimovic L,Milisavljevic S. Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small cell lung cancer. J Clin Oncol. 1997; 15: 893900.
  • 54
    Jeremic B,Shibamoto Y,Nikolic N, et al. The role of radiation therapy in the combined modality treatment of patients with extensive disease small-cell lung cancer (ED SCLC): a randomized study. J Clin Oncol. 1999; 17: 20922099.
  • 55
    Jeremic B,Shibamoto Y,Acimovic L, et al. Carboplatin, etoposide, and accelerated hyperfractionated radiotherapy for elderly patients with limited small cell lung cancer. A phase II study. Cancer. 1998; 82: 836841.
  • 56
    Jeremic B,Shibamoto Y,Milicic B, et al. Concurrent accelerated hyperfractionated radiation therapy and carboplatin/oral etoposide in elderly patients with stage III non-small-cell lung cancer. a phase II study. Int J Radiat Oncol Biol Phys. 1999; 44: 343348.
  • 57
    Jeremic B,Shibamoto Y,Stanisavljevic B, et al. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial. Radiother Oncol. 1997; 43: 2937.
  • 58
    Jeremic B,Shibamoto Y,Milicic B, et al. Hyperfractionated radiation therapy with or without concurrent low-dose cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol. 2000; 18: 14581464.
  • 59
    Jeremic B,Milicic B,Acimovic L, et al. Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin/paclitaxel in patients with stage III non-small cell lung cancer (NSCLC). Long-term results of a phase II study. J Clin Oncol. 2005; 23: 11441151.